Galderma announces the launch of FACE by Galderma™ – a game-changing augmented reality solution that helps healthcare professionals grow their business and improve patient satisfaction

  • FACE by Galderma™ is a cutting-edge visible aesthetic software that simulates the outcomes of injectable therapies in actual time, utilizing digital facial evaluation.

  • The app gives superior wrinkle detection in addition to the potential outcomes of 19 injectable therapies, that are displayed as dynamic ‘earlier than and after’ photographs.

  • The answer gives a holistic strategy to individualized care, enabling sufferers to observe by means of with their remedy plan with confidence

  • In a worldwide pilot research, 80% of contributors stated the app helped them perceive their remedy choices. In the meantime, 85% acknowledged they might suggest the app, and 91% stated they plan to return to their practitioner to proceed their remedy plan.1

ZUG, Switzerland, January 26, 2023– (working wire) – Galderma proclaims the launch of FACE by Galderma™, an progressive augmented actuality software. The groundbreaking answer allows aesthetic practitioners and sufferers to visualise remedy outcomes on the strategy planning stage. The expertise might be offered to the aesthetic scientific neighborhood on the World Congress of the Worldwide Grasp Course on Gerontology (IMCAS) 2023 in Paris on January 26-28.

FACE by Galderma™ offers sufferers a sensible, real-time “earlier than and after” view of the potential outcomes from an individualized remedy plan. This helps handle considerations about ultimate outcomes whereas enabling a greater understanding of the holistic remedy strategy, in the end resulting in elevated affected person satisfaction1.

“We developed this game-changing answer to assist aesthetic practitioners and provides sufferers a visible illustration of what they will anticipate from the procedures included of their remedy plan. For instance, the injectable outcomes characteristic simulates in actual time how a remedy can increase a affected person’s lips. Or cheeks, or chin. FACE by Galderma™ gives sufferers with a sensible view of their outcomes earlier than remedy begins, supporting them to set remedy objectives and priorities along with their practitioner. It offers them the liberty to make their aesthetic objectives a actuality.”

Jerry Muhl

Head of World Enterprise Unit, Aesthetics
Galderma

FACE by Galderma™ permits for a completely immersive and interactive session course of and allows the aesthetic practitioner to guage all the face in actual time. The evaluation is predicated on Galderma’s 5 Faces evaluation which takes into consideration pores and skin high quality, facial form, facial symmetry, facial proportions and contour, in addition to animation and emotional expression. After analysis, precedence areas might be recognized, and an individualized remedy plan might be developed. By taking a full-face strategy, FACE by Galderma™ ensures that the practitioner gives a complete remedy plan that meets the affected person’s wants. The expertise behind FACE was developed by Galderma™ in partnership with Crisalix, the main international authority on 3D, digital actuality, and augmented actuality aesthetic simulations.

“FACE by Galderma™ heralds a degree of innovation by no means earlier than seen within the aesthetics business. This distinctive expertise has the potential to vary the way in which consultations are performed and is good for showcasing the capabilities of Galderma’s spectacular portfolio of injectables.”

Jamie Garcia
chief government officer
disaster

The outcomes of a worldwide flagship research not too long ago performed by Galderma™ are very promising. Of the respondents, 80% stated the app helped them perceive their remedy choices, whereas 73% agreed that it bought them desirous about a process they hadn’t thought-about earlier than. Whereas 61% acknowledged that they plan to indicate their “earlier than and after” photographs to associates. Total, 85% stated they might suggest the app, and 91% stated they plan to return to their practitioner to proceed their individualized remedy plan.1.

“Sufferers come to my clinic for a session as a result of they’re interested by an injectable beauty process, they typically have questions and concern how the process will end up and whether or not it’ll look pure and deal with their wrinkles. The superior expertise out there through the brand new FACE by Galderma instrument gives my sufferers with a simulation of their outcomes earlier than the process, which is able to You assist alleviate their fears and construct confidence.”

Alexandra Bielawiec

Nurse Practitioner and Aesthetic Grasp Injector

REGENCY MEDICAL SPA & HAIR CLINIC in Barrington, Illinois

FACE by Galderma™ options 19 doable injectable outcomes utilizing merchandise from the Galderma portfolio (relying on native indications), permitting sufferers to see simulated photographs in actual time. Remedy choices embody:

  • Neuromodulators, similar to DYSPORT®Azlor® (EU) and ALLUZIENCE® (The primary ready-to-use liquid botulinum toxin kind A, authorized in June 2021 to be used in Europe (excluding Greece, Lithuania, Estonia, Latvia and Hungary)).

  • Biostimulants, together with SCULPTRA®

  • Merchandise from the vary of hyaluronic acid fillers, RESTYLANE® and RESTYLANE® Tonics

The instrument additionally facilitates affected person administration, appearing as a ‘affected person’s passport’. Clinics allow to retailer all affected person information in a single place, together with remedy plan, video, “earlier than and after” photographs, and appointment schedules. Sufferers can even entry a FACE by Galderma™ account and look at a person affected person profile from house.

FACE by Galderma™ might be out there within the US and Brazil within the first half of 2023, with a worldwide rollout throughout Latin America, Europe, the Center East, Canada and Asia all through 2023.

About Galderma
Galderma is the chief within the dermatology class, current in practically 90 nations. We provide an progressive, science-based portfolio of main premium manufacturers and companies spanning the complete spectrum of the quickly rising dermatology market by means of injectable cosmetics, dermatological cosmetics and therapeutic dermatology. Since our founding in 1981, we have devoted our focus and keenness to the human physique’s largest organ – the pores and skin – to assembly particular person client and affected person wants and attaining superior ends in partnership with healthcare professionals. As a result of we perceive that pores and skin shapes our lives, we’re growing dermatology for each pores and skin story. for extra data: www.galderma.com

About Crisalix
Crisalix is ​​the worldwide on-line simulation and imaging commonplace for pre and submit beauty, reconstructive or dermatological therapies, supporting healthcare professionals and educating sufferers on their choices. With our on-line disruptive imaging answer, powered by the newest AI and pc imaginative and prescient applied sciences, our unique platform is utilized by sufferers, main medical-aesthetic manufacturers and essentially the most recognizable medical suppliers all through all the affected person journey. With unbeaten key enhancements on key medical information and associated enterprise metrics, we deal with enhancing the wonder journey of individuals world wide, day in and day trip, by remodeling 3D, 4D, Digital Actuality, and Augmented Actuality visualization.

About Alluzience® (liquid botulinum toxin kind A)
Alluzience (liquid botulinum toxin kind A) is the primary ready-to-use liquid BoNT-A neuromodulator to be launched in Europe. Alluzience ought to solely be administered by a doctor with applicable {qualifications} and expertise on this remedy utilizing the required tools.2 Dosages and remedy intervals rely on an evaluation of the person affected person’s response.2 The remedy interval shouldn’t be greater than three months.2 For extra data, please see the abstract of product traits.2

Alluzience is produced beneath license from Ipsen. Alluzience is a registered trademark of Ipsen. Galderma has the unique license from Ipsen to develop, promote and distribute Alluzience within the authorized index in a number of European nations.

About disport® / Azalure®
Dysport (abobotulinumtoxinA) is an injection indicated for the momentary enchancment within the look of average to extreme frown traces between the eyebrows (glabellar traces) in adults youthful than 65 years of age. Dysport can also be marketed as Azzalure3 Within the EU for the remedy of glabellar traces and lateral canthal traces. Dysport has greater than 30 years of scientific expertise worldwide in therapeutic indications and 13 years in aesthetic indications, with complete scientific proof of security and efficacy. Dysport is licensed for aesthetic indications in 85 markets worldwide and is among the world’s main manufacturers of aesthetic neuromodulators with over 100 million therapies delivered in aesthetic indications up to now.

Dysport is a product beneath license from and manufactured by Ipsen. Since 2009, Galderma and Ipsen have established a strategic partnership whereby Galderma has been selling and distributing Ipsen’s botulinum toxin kind A merchandise in aesthetic indications. Ipsen-Galderma’s strategic partnership now covers China, the US, Europe, the Center East, Australia, South Korea, Canada, Brazil, Argentina and another nations. Ipsen continues to advertise Dysport in sure therapeutic indications in nations world wide. For extra details about Ipsen, go to www.ipsen.com.

About Restylane®
RESTYLANE is the unique non-animal hyaluronic acid filler with over 25 years of accomplishment and over 50 million therapies worldwide. NASHA™ and OBT™ applied sciences make RESTYLANE the world’s most versatile line of fillers to ship really particular person outcomes.4,5

Restylane® The product vary contains RESTYLANE®Restylane® LYFT™, RESTYLANE® KYSSE™, RESTYLANE® VOLYME™, RESTYLANE® DEFYNE™, RESTYLANE® REFYNE™, RESTYLANE® EYELIGHT™ and RESTYLANE® SKINBOOSTERS VITAL™.

About Sculptra®
SCULPTRA stimulates collagen manufacturing within the pores and skin6 It’s appropriate for augmenting depressed areas, particularly for correcting pores and skin depressions similar to pores and skin creases, wrinkles, folds, scars and indicators of pores and skin getting old.7 SCULPTRA can also be appropriate for correcting massive indicators of facial fats loss (lipoatrophy).7

SCULPTRA is an injectable biostimulator containing microparticles of poly-L-lactic acid (PLLA) that steadily revitalizes the pores and skin’s structural basis, offering natural-looking, long-term outcomes for as much as 25 months.8 SCULPTRA was first authorized in 1999 in Europe and is at present out there in additional than 40 nations world wide.

References
1. Pilot research of sufferers utilizing the FACE app, November 2020 – September 2021
2. Alluzience Abstract of Product Traits, June 10, 2021
3. Azzalure SMPC
4. Knowledge on file (MA-33939).
5. Öhrlund A. Poster Offered at AMWC 2019
6. Bohnert Ok et al. Reconstructive Plastic Surgical procedure 2019; 127 (4): 1684-92
7. Sculptra IFU. 2018
8. Brown SA et al. Reconstructive Surgical procedure 2011; 127 (4): 1684-92

View supply model on businesswire.com: https://www.businesswire.com/information/house/20230125005814/ar/

Contacts

The media
Christian Marco, MA
Chief of Communications
christian.marcoux@galderma.com
+41 76 315 26 50

Rachel Mooney
World Franchise Communications
rachel.mooney@galderma.com
+41 76 261 64 41

Sebastian Cross
Company Communications Supervisor
sebastien.cros@galderma.com
+41 79529 59 85

Leave a Comment